Stocks
306549CMRG
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare diseases, with a focus on genetic disorders. Its lead programs target conditions with high unmet medical need, and investors track it for pipeline catalysts and regulatory milestones.
Congressional Interest in 306549 (CMRG)
1 member of Congress has disclosed 1 trade in 306549 (CMRG), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading CMRG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-03-17 | JAMES B. RENACCI | sell | $1K-$15K |